![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
How to defuse a demographic time bomb: the way forward?
-
Article
Response to: 'Direct ophthalmoscopy should be taught to undergraduate medical students'
-
Article
The diagnostic accuracy of spectral-domain optical coherence tomography for neovascular age-related macular degeneration: a comparison with fundus fluorescein angiography
To evaluate the diagnostic accuracy of spectral-domain optical coherence tomography (SD-OCT) for neovascular age-related macular degeneration (nAMD): a comparison against fundus fluorescein angiography (FFA).
-
Article
Optical coherence tomography for the diagnosis of neovascular age-related macular degeneration: a systematic review
The purpose is to study the diagnostic performance of optical coherence tomography (OCT) and alternative diagnostic tests for neovascular age-related macular degeneration (nAMD). Methods employed are as follow...
-
Article
Erratum: Redesigning services for the management of vitreomacular traction and macular hole
Correction to: Eye (2014) 28, S1–S10; doi:10.1038/eye.2014.125 Since the publication of the above article, it has been noted that the incorrect Creative Commons License logo and text were given. The details ar...
-
Article
Open AccessRedesigning services for the management of vitreomacular traction and macular hole
Vitreomacular traction (VMT) and VMT with macular hole (MH) are serious conditions, being associated with visual disturbance, for example, metamorphopsia, and diminished visual acuity (VA). Pars plana vitrecto...
-
Article
Erratum: Ranibizumab for the treatment of choroidal neovascularisation secondary to pathological myopia: interim analysis of the REPAIR study
Correction to: Eye (2013), 27, 709–715; doi:10.1038/eye.2013.8; published online 1 March 2013 Since the publication of the above article, it has been noted that a line appeared incorrectly between RETREATMENT ...
-
Article
Erratum: Ranibizumab for the treatment of choroidal neovascularisation secondary to pathological myopia: interim analysis of the REPAIR study
Correction to: Eye (2013) 27, 709–715; doi:10.1038/eye.2013.8; published online 1 March 2013 Since online publication of the above article, the authors have noted that the names of the fifth and ninth authors ...
-
Article
Ranibizumab for the treatment of choroidal neovascularisation secondary to pathological myopia: interim analysis of the REPAIR study
To evaluate the efficacy and safety of intravitreal ranibizumab in patients with choroidal neovascularisation secondary to pathological myopia (myopic CNV). Data are from a pre-planned, 6-month interim analysis.
-
Article
Microperimetric changes in neovascular age-related macular degeneration treated with ranibizumab
To assess the value of microperimetry in eyes with neovascular age-related macular degeneration previously treated with ranibizumab and now in the maintenance phase of therapy.
-
Article
Open AccessAction on AMD. Optimising patient management: act now to ensure current and continual delivery of best possible patient care
In recent years, there have been significant advances in the clinical management of patients with wet age-related macular degeneration (wet AMD)—a rapidly progressing and potentially blinding degenerative eye ...
-
Article
Performance in the Duke–Elder ophthalmology undergraduate prize examination and future careers in ophthalmology
Cognitive factors (eg, academic achievement) have had a significant role in selecting postgraduate surgical trainees in the past. This project sought to determine the role of a national undergraduate ophthalmo...
-
Article
Ranibizumab: The clinician's guide to commencing, continuing, and discontinuing treatment